1.Hydroxychloroquine for COVID-19: A Single Center, Retrospective Cohort Study
Wen Chung Ho ; Wei Xin Yong ; Khai Shin Tan ; Woh Yon Mak ; Mandeep Kaur Gill ; Agnes Hui Ching Lok ; Shazwani Zulkifli ; Salmah Idris ; Khairil Erwan Khalid ; Chee Loon Leong ; Kang Nien How
Malaysian Journal of Medicine and Health Sciences 2023;19(No.2):8-13
		                        		
		                        			
		                        			Introduction: The outbreak of coronavirus disease (COVID-19) in December 2019 called for a rapid solution, leading to repurposing of existing drugs. Due to its immunomodulatory effect and antiviral properties, hydroxychloroquine (HCQ) has been used in early 2020 for treatment of COVID-19 patients. This study was conducted to evaluate 
the treatment outcome of HCQ monotherapy in Malaysia. Methods: A retrospective cohort study was conducted in 
COVID-19 ward in Hospital Kuala Lumpur (HKL), from March to April 2020. A total of 446 COVID-19 patients were 
recruited, only 325 patients were finally included for analysis. Statistical analysis was done using SPSS, with a significant value set at p<0.05. Results: The mean age of the patients were 38.5 ±15.5. They were majority male, (n=210, 
64.6%) Malaysian (n=239, 73.5%) and Malay ethnicity (n=204, 62.8%). Ninety-one (28%) patients received HCQ 
monotherapy. HCQ monotherapy was associated with worse outcome (OR: 10.29, 95% CI 1.17-90.80). There was a 
significant difference in mean length of stay between those with and without HCQ treatment (t323=5.868, p<0.001, 
95% CI, 2.56-5.31). The average length of stay for HCQ treated group was 3.84 days longer than those without 
treatment. 6.6% of the patient receiving HCQ monotherapy encountered adverse drug effects. Conclusion: Similar 
to study reported worldwide, our study demonstrated that HCQ did not improve length of stay and the outcome of 
COVID-19 patients. 
		                        		
		                        		
		                        		
		                        	
2.Clinical Characteristics of Anogenital Warts Among Patients Attending Genitourinary Medicine Clinic Hospital Kuala Lumpur Between 2015 and 2020
Khai Shin Tan ; Vijayaletchumi Krishnasamy ; Suganthi Thevarajah ; Min Moon Tang
Malaysian Journal of Dermatology 2022;48(Jun 2022):66-75
		                        		
		                        			Background:
		                        			Anogenital human papillomavirus (HPV) is the most frequent reported sexually transmitted infection in 
the world. We aim to describe the local demographic data and the clinical characteristics of anogenital 
warts (AGWs).
		                        		
		                        			Methods:
		                        			This is a retrospective study on all patients with AGWs who attended the GUM clinic between 2015 
and 2020. Data was obtained from case notes and further analysed.
		                        		
		                        			Results:
		                        			A total of 935 patients with AGWs attended the GUM clinic between 2015 and 2020. The mean 
age was 30.4 years (range 12-84). The male to female ratio was 2.35:1. Majority were Malaysian 
(97%). Majority of the Malaysian were Malays (61.5%) followed by Chinese (27.7%) and Indian 
(8.9%). About 5.6% had a history of substance abuse. While the majority (57.9%) were heterosexual, 
34.8% were homosexual and 6.4% were bisexual. About 59.8% had more than one sexual partner. 
A quarter (25.6%) was infected with the human immunodeficiency virus. The most frequent site of 
AGWs in males was the perianal area (52.6%), followed by the penis (45.7%), and with a fifth of 
them having lesions at multiple sites. For female patients, the most frequent site of AGWs was the 
posterior fourchette (45.2%) followed by the labia minora (33%) with 46.6% had involvement at 
multiple sites. Approximately 17.6% had other concomitant sexually transmitted infections. Local 
treatment application used included cryotherapy (86.4%), podophyllin (35.3%), tri-chloroacetic acid 
(26.8%) and imiquimod (2.6%). About 41.5% required combination of these modalities. Nearly 6.2% 
experienced recurrence. About 2% required surgical intervention.
		                        		
		                        			Conclusions
		                        			AGWs was more commonly observed in male. The most frequent site of involvement was perianal for 
male (52.6%) and posterior fourchette in female (45.2%). 
		                        		
		                        		
		                        		
		                        			Papillomavirus Infections
		                        			;
		                        		
		                        			 Sexually Transmitted Diseases
		                        			
		                        		
		                        	
            

Result Analysis
Print
Save
E-mail